Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The BTD thing

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Nov 30, 2021 9:29am

499 Views

Post# 34179428

RE:RE:RE:RE:The BTD thing

All I have to add to this topic, is that from my reading and understanding, FT or BT, either one will lead to Accelerated Approval(commercialization) IF the durable CR data supports it after the 450days or so that the FDA has specd for TLT.

Like Slayer said BT designation could be an upgrade to the current FT if the 90day CR %s continue at this rate, or improve. That could happen any time, I imagine TLT will be applying for that...

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages